ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Madrigal Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Madrigal Pharmaceuticals, INC. (Madrigal Pharmaceuticals, INC. 401(k) Plan · EIN 04-3508648 · PN 001): $37.60M net assets, 544 active participants, and $7.31 per $10,000 (7.31 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorMadrigal Pharmaceuticals, INC.
Filing IdentifierMadrigal Pharmaceuticals, INC. 401(k) Plan · EIN 04-3508648 · PN 001
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$37.60M
Active Participants544
Direct Admin Fee Rate$7.31 per $10,000 (7.31 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($796,592, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI